阅读时间：3分钟
Huntsman Cancer Institute has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Translational researchers extend basic discoveries made in the laboratory and apply them to solve 临床 problems and benefit patients through new diagnostic and therapeutic approaches.
Recognition as a Huntsman Translational Scholar provides financial support to promote cancer-focused studies that accelerate the development of new treatments. The six awardees will also work as a cohesive team to share best practices and mentor other scientists interested in translational cancer research. “The Huntsman Translational Scholars is an initiative designed to recognize and advance the careers of exceptional scientists who are making strides in translational research,” says Huntsman Cancer Institute Director and CEO 玛丽Beckerle.
马修·波普，医学博士, is a physician-scientist at Huntsman Cancer Institute and an associate professor in the Department of 放射肿瘤学 at the University of Utah. He is also a member of the pediatric, 肉瘤, 乳房 multidisciplinary teams at Huntsman Cancer Institute and serves as director of the residency program in the Department of 放射肿瘤学.
As the primary radiation oncologist providing radiation for children with cancer, Poppe is actively engaged in the Children’s Oncology Group (COG), the world’s largest organization devoted exclusively to childhood and adolescent cancer research. He conducts translational, 临床, outcomes research at Huntsman Cancer Institute and works with COG in the design of new pediatric 临床 trials. Poppe is currently the radiation co-chair of a phase III 临床 trial focused on patients newly diagnosed with high-risk B-cell acute lymphoblastic leukemia (B-ALL).
In addition to his 临床 research centered on pediatric cancers, Poppe is actively engaged in diverse institutions that are improving medical care for 乳房 cancer patients. He currently serves as co-chair of the Breast Local Control Group and as vice-chair of the 乳房 committee for the Alliance Cooperative Trials Group. As a member of the National Cancer Institute’s 乳房 cancer steering committee, Poppe contributes passionately to the Breast Oncology Local Disease (BOLD) Task Force, which was established to provide early input into studies of localized 乳房 cancer treated with surgery or radiation therapy. As the principal investigator of an international phase III 临床 trial, Poppe is evaluating the safety and efficacy of short course radiation in mastectomy patients who elect to have 乳房 reconstruction. He is also the principal investigator of a phase II 临床 trial to evaluate a novel nine-day accelerated regimen of whole 乳房 radiation.
“As a researcher and clinician, I have the opportunity to treat and interact with patients as well as try to find new solutions to improve the lives of cancer patients,波普说。. “Through 临床 trials, we hope to find new ways to improve treatments and increase the quality of life for people with cancer.”
Poppe has published 34 peer-reviewed manuscripts and three book chapters. He has presented numerous posters at national and international meetings.
Poppe earned a bachelor’s degree in mechanical engineering from Santa Clara University and worked in engineering projects at the NASA Ames 研究 Center before attending medical school at Oregon Health Sciences University. He then completed a family practice residency at the University of California Davis, entered active duty in the United States Air Force, practiced family and aerospace medicine until 2006.
To obtain additional specialized training, Poppe pursued and completed a radiation oncology residency at the Rutgers Cancer Institute of New Jersey. 在此期间, he contributed to residency education by serving as a member of the Accreditation Council for Graduate Medical Education and executive member of the Association of Residents in 放射肿瘤学.